Brett Stark1, Jaclyn M W Hughto2, Brittany M Charlton3, Madeline B Deutsch4, Jennifer Potter5, Sari L Reisner6. 1. Department of Obstetrics & Gynecology, University of California San Francisco, San Francisco, CA; Department of Social & Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA. 2. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI; Department of Epidemiology, Brown University School of Public Health, Providence, RI; Center for Health Equity Research, Brown University, Providence, RI; The Fenway Institute, Fenway Health, Boston, MA. 3. Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. 4. Department of Family & Community Medicine, University of California, San Francisco, CA; Center of Excellence for Transgender Health, University of California San Francisco, San Francisco, CA. 5. The Fenway Institute, Fenway Health, Boston, MA; Department of General Medicine, Beth Israel Deaconess Medical Center, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA. 6. The Fenway Institute, Fenway Health, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; Division of General Pediatrics, Boston Children's Hospital, Boston, MA. Electronic address: sari.reisner@childrens.harvard.edu.
Abstract
OBJECTIVES: This study aims to identify factors associated with the reproductive planning of trans-masculine adults. STUDY DESIGN: Between 2015 and 2016, providers enrolled 150 trans-masculine adults in a sexual health study assessing sociodemographics, social support, gender affirmation, sexual partnering, and reproductive history and planning. A brief clinical interview assessed contraceptive use and concerns. Bivariate and multivariable logistic regression analyses examined associations between participant characteristics and three outcomes: current contraceptive use, lifetime pregnancy history and reproductive planning. RESULTS: Overall, 37.3% are currently using contraceptives; 5.3% have been pregnant; and 20.0% plan to have biological children (9.3% plan to become pregnant; 12.0% plan to use their oocytes with a surrogate). Participants are less likely to use contraceptives if they are students vs. not, have socially affirmed their gender vs. not and have a partner vs. are single. Greater number of sexual partners is associated with the increased odds of contraceptive use. Further, as social support increases, the odds of having been pregnant decreases. Participants with a nonbinary gender identity are more likely to want to become pregnant than those with a binary gender identity, whereas those who have socially affirmed their gender are less likely to want to become pregnant than those who had not. Finally, participants of color more commonly planned to use their oocytes with a surrogate than white participants. CONCLUSION: Sociodemographic, gender affirmation, social support and sexual partner factors are associated with contraceptive use and reproductive history among trans-masculine patients. IMPLICATIONS: Healthcare providers must be aware of the diverse reproductive histories and pregnancy goals of trans-masculine individuals in order to provide comprehensive reproductive healthcare counseling and provision. More research is needed to better understand contraception and reproduction desires in trans-masculine individuals.
OBJECTIVES: This study aims to identify factors associated with the reproductive planning of trans-masculine adults. STUDY DESIGN: Between 2015 and 2016, providers enrolled 150 trans-masculine adults in a sexual health study assessing sociodemographics, social support, gender affirmation, sexual partnering, and reproductive history and planning. A brief clinical interview assessed contraceptive use and concerns. Bivariate and multivariable logistic regression analyses examined associations between participant characteristics and three outcomes: current contraceptive use, lifetime pregnancy history and reproductive planning. RESULTS: Overall, 37.3% are currently using contraceptives; 5.3% have been pregnant; and 20.0% plan to have biological children (9.3% plan to become pregnant; 12.0% plan to use their oocytes with a surrogate). Participants are less likely to use contraceptives if they are students vs. not, have socially affirmed their gender vs. not and have a partner vs. are single. Greater number of sexual partners is associated with the increased odds of contraceptive use. Further, as social support increases, the odds of having been pregnant decreases. Participants with a nonbinary gender identity are more likely to want to become pregnant than those with a binary gender identity, whereas those who have socially affirmed their gender are less likely to want to become pregnant than those who had not. Finally, participants of color more commonly planned to use their oocytes with a surrogate than white participants. CONCLUSION: Sociodemographic, gender affirmation, social support and sexual partner factors are associated with contraceptive use and reproductive history among trans-masculine patients. IMPLICATIONS: Healthcare providers must be aware of the diverse reproductive histories and pregnancy goals of trans-masculine individuals in order to provide comprehensive reproductive healthcare counseling and provision. More research is needed to better understand contraception and reproduction desires in trans-masculine individuals.
Authors: Sarah M Peitzmeier; Madina Agénor; Ida M Bernstein; Michal McDowell; Natalie M Alizaga; Sari L Reisner; Dana J Pardee; Jennifer Potter Journal: Qual Health Res Date: 2017-08-24
Authors: Rebecca L Taub; Simon Adriane Ellis; Genevieve Neal-Perry; Amalia S Magaret; Sarah W Prager; Elizabeth A Micks Journal: Am J Obstet Gynecol Date: 2020-02-08 Impact factor: 8.661